At DigiPharm Europe 2010 Conference in London on 29 September, Paul Grant and Daniel Ghinn presented the highlights of a global study into reportable adverse events found online by therapeutic area, brand and territory.
The research was one of the most extensive studies of its kind ever conducted, and was carried out by nine of Creation Healthcare’s international team of consultants based in seven countries.
The DigiPharm session included some interesting dialogue with conference participants, who shared their own experiences of adverse events monitoring.
The session concluded with a challenge to pharmaceutical professionals in marketing, communications and pharmacovigilence to collaborate, using these insights to develop appropriate strategies in their own companies.
View the slides below, or for more options and accompanying notes, view our SlideShare Account: